Colorectal cancer remains the second leading cause of cancer-related mortality in the United States. Although surgical resection is still the primary treatment for colorectal cancer, in recent years, there has been a remarkable progress in the development of new therapies to treat colorectal cancer. Response rates have increased substantially and new immunotherapeutic approaches are shedding new light in the battle against the disease. This review will focus on the current immunotherapeutic approaches being developed and will discuss clinical data for some of these new treatments.
Colorectal cancer: new advances in immunotherapy. Publishing Authors By Initials
Colorectal cancer: new advances in immunotherapy. Journal Published:
PUBLICATION TYPE: Review
Journal: Cancer biology & therapy
VOLUME: 6
Page Numbers: 11-7
Journal Abbreviation: Cancer Biol. Ther.
ISSN: 1538-4047
DAY: 3
MONTH: Jan
YEAR: 2007
Colorectal cancer: new advances in immunotherapy. Information
Number of References: 66
LANGUAGE: eng
NlmUniqueID: 101137842
Colorectal cancer: new advances in immunotherapy. Keywords Mesh Terms:
KEYWORDS: Immunotherapy
MESH TERMS: trends
Chemical & Substance for Abstract: Colorectal cancer: new advances in immunotherapy. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Colorectal cancer: new advances in immunotherapy.
AFFILIATION: Department of Molecular Virology and Microbiology, Molecular Surgeon Research Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas USA.
Country: United States
AGENCY: United States NCCAM
GRANT: R21 AT003094
ACRONYM: AT
MEDLINETA: Cancer Biol Ther
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Colorectal cancer: new advances in immunotherapy Related Publications